Domain swapping of complementarity-determining region in nanobodies produced by Pichia pastoris.
CD4 nanobody
CDR swapping
GFP nanobody
Pichia pastoris
Relative binding ability
Journal
AMB Express
ISSN: 2191-0855
Titre abrégé: AMB Express
Pays: Germany
ID NLM: 101561785
Informations de publication
Date de publication:
15 Jul 2019
15 Jul 2019
Historique:
received:
15
03
2019
accepted:
05
07
2019
entrez:
17
7
2019
pubmed:
17
7
2019
medline:
17
7
2019
Statut:
epublish
Résumé
Easy preparation of chimeric nanobodies with various scaffolds is important for customizing abilities of nanobodies toward practical utilization. To accomplish high-throughput production of various nanobodies, utilization of microbes is an attractive option. In the present study, various chimeric nanobodies were prepared using the methylotrophic yeast Pichia pastoris. We designed chimeric nanobodies with complementarity-determining regions (CDRs) against green fluorescent protein (GFP) or cluster of differentiation 4 (CD4) based on the scaffold of GFP-nanobody. FLAG-tagged chimeric nanobodies were prepared by one-step cloning and produced using P. pastoris. Secreted chimeric nanobodies were purified from the culture media of P. pastoris transformants. Relative binding abilities of purified chimeric nanobodies to GFP and CD4 was tested using a BIACORE T-200. P. pastoris successfully produced a high yield of FLAG-tagged chimeric nanobodies. FLAG-tagged GFP- and CD4-nanobodies were shown to specifically bind to GFP and CD4, respectively. Chimeric nanobodies, in which the CDR2 or 3 of GFP-nanobody was replaced with CDRs of CD4-nanobody, acquired the ability to bind to CD4 without binding to GFP. These results demonstrate successful production of functional chimeric nanobodies using P. pastoris. These results also suggest that swapping of CDRs, especially CDRs 2 or 3, potentially enables a novel method of creating nanobodies.
Identifiants
pubmed: 31309388
doi: 10.1186/s13568-019-0833-2
pii: 10.1186/s13568-019-0833-2
pmc: PMC6629726
doi:
Types de publication
Journal Article
Langues
eng
Pagination
107Subventions
Organisme : JST-CREST
ID : JPMJCR16G2
Organisme : JSPS Research Fellowship for Young Scientists
ID : 16J08791
Références
Antimicrob Agents Chemother. 2001 Oct;45(10):2807-12
pubmed: 11557473
Curr Opin Biotechnol. 2002 Aug;13(4):329-32
pubmed: 12323354
Methods Mol Biol. 2004;267:15-52
pubmed: 15269414
Appl Microbiol Biotechnol. 2005 Jan;66(4):384-92
pubmed: 15378291
Methods. 2005 May;36(1):3-10
pubmed: 15848070
J Mol Biol. 2005 Sep 23;352(3):597-607
pubmed: 16095608
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Nat Methods. 2006 Nov;3(11):887-9
pubmed: 17060912
Bioinformatics. 2007 Nov 1;23(21):2947-8
pubmed: 17846036
Protein Expr Purif. 2009 May;65(1):77-82
pubmed: 19007889
J Biol Chem. 2009 Jan 30;284(5):3273-84
pubmed: 19010777
J Nucl Med. 2010 May;51(5):782-9
pubmed: 20395332
Protein Sci. 2010 Dec;19(12):2389-401
pubmed: 20945358
Immunol Invest. 2011;40(3):299-338
pubmed: 21244216
J Biochem. 2011 Oct;150(4):431-8
pubmed: 21646240
Protein Eng Des Sel. 2012 Jan;25(1):39-46
pubmed: 22143875
Biotechnol Appl Biochem. 2012 Jan-Feb;59(1):15-21
pubmed: 22332740
Appl Microbiol Biotechnol. 2012 Oct;96(1):81-8
pubmed: 22644525
Methods Mol Biol. 2012;911:287-303
pubmed: 22886259
Front Immunol. 2013 Jul 29;4:217
pubmed: 23908655
PLoS One. 2013 Oct 15;8(10):e77678
pubmed: 24143255
Microb Cell Fact. 2013 Nov 18;12:113
pubmed: 24245806
Nat Protoc. 2014 Mar;9(3):674-93
pubmed: 24577359
Biotechnol Appl Biochem. 2016 Mar-Apr;63(2):200-5
pubmed: 24673401
Trends Biotechnol. 2014 May;32(5):263-70
pubmed: 24698358
Nature. 2014 Nov 27;515(7528):554-7
pubmed: 25252978
J Transl Med. 2014 Dec 10;12:343
pubmed: 25496223
Mol Biosyst. 2016 Jul 19;12(8):2342-58
pubmed: 27306919
Elife. 2016 Jul 19;5:
pubmed: 27434673
Turk J Med Sci. 2017 Apr 18;47(2):695-701
pubmed: 28425268
Front Immunol. 2017 Apr 10;8:420
pubmed: 28443097
ACS Infect Dis. 2017 Jul 14;3(7):479-491
pubmed: 28591513
Front Immunol. 2017 Jul 04;8:771
pubmed: 28725224
Front Immunol. 2017 Nov 02;8:1442
pubmed: 29163515
Front Immunol. 2017 Nov 22;8:1603
pubmed: 29213270
Nat Struct Mol Biol. 2018 Mar;25(3):289-296
pubmed: 29434346
Elife. 2018 May 24;7:
pubmed: 29792401
Nat Methods. 2019 May;16(5):421-428
pubmed: 31011184
PLoS One. 2019 Apr 23;14(4):e0215993
pubmed: 31013333
Nature. 1993 Jun 3;363(6428):446-8
pubmed: 8502296
Nat Biotechnol. 1997 Jun;15(6):553-7
pubmed: 9181578
FEBS Lett. 1997 Sep 15;414(3):521-6
pubmed: 9323027